Global Over-The-Counter (OTC) Pet Medication Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Over-The-Counter (OTC) Pet Medication market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Over-The-Counter (OTC) Pet Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Over-The-Counter (OTC) Pet Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Over-The-Counter (OTC) Pet Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Over-The-Counter (OTC) Pet Medication include Merck Animal Health, Elanco, Zoetis, Virbac, Vet's Best, Vetoquinol, Sentry, Purdue Pharma L.P. and PetIQ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Over-The-Counter (OTC) Pet Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over-The-Counter (OTC) Pet Medication.

The Over-The-Counter (OTC) Pet Medication market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Over-The-Counter (OTC) Pet Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Over-The-Counter (OTC) Pet Medication Segment by Company

Merck Animal Health
Elanco
Zoetis
Virbac
Vet's Best
Vetoquinol
Sentry
Purdue Pharma L.P.
PetIQ
Perrigo
Nutramax Laboratories
Mobedco-Vet
Ceva Santé Animale
Boehringer Ingelheim
Antelope Pets

Over-The-Counter (OTC) Pet Medication Segment by Type

Dogs
Cats
Others

Over-The-Counter (OTC) Pet Medication Segment by Application

Online Sales
Offline Sales

Over-The-Counter (OTC) Pet Medication Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-The-Counter (OTC) Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Over-The-Counter (OTC) Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-The-Counter (OTC) Pet Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Over-The-Counter (OTC) Pet Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Over-The-Counter (OTC) Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Over-The-Counter (OTC) Pet Medication Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Estimates and Forecasts (2020-2031)
1.3 Over-The-Counter (OTC) Pet Medication Market by Type
1.3.1 Dogs
1.3.2 Cats
1.3.3 Others
1.4 Global Over-The-Counter (OTC) Pet Medication Market Size by Type
1.4.1 Global Over-The-Counter (OTC) Pet Medication Market Size Overview by Type (2020-2031)
1.4.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size Review by Type (2020-2025)
1.4.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2020-2025)
1.5.2 Europe Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2020-2025)
1.5.4 South America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Over-The-Counter (OTC) Pet Medication Industry Trends
2.2 Over-The-Counter (OTC) Pet Medication Industry Drivers
2.3 Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges
2.4 Over-The-Counter (OTC) Pet Medication Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Over-The-Counter (OTC) Pet Medication Revenue (2020-2025)
3.2 Global Top Players by Over-The-Counter (OTC) Pet Medication Sales (2020-2025)
3.3 Global Top Players by Over-The-Counter (OTC) Pet Medication Price (2020-2025)
3.4 Global Over-The-Counter (OTC) Pet Medication Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Over-The-Counter (OTC) Pet Medication Major Company Production Sites & Headquarters
3.6 Global Over-The-Counter (OTC) Pet Medication Company, Product Type & Application
3.7 Global Over-The-Counter (OTC) Pet Medication Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Over-The-Counter (OTC) Pet Medication Market CR5 and HHI
3.8.2 Global Top 5 and 10 Over-The-Counter (OTC) Pet Medication Players Market Share by Revenue in 2024
3.8.3 2023 Over-The-Counter (OTC) Pet Medication Tier 1, Tier 2, and Tier 3
4 Over-The-Counter (OTC) Pet Medication Regional Status and Outlook
4.1 Global Over-The-Counter (OTC) Pet Medication Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size by Region
4.2.1 Global Over-The-Counter (OTC) Pet Medication Sales in Volume by Region (2020-2025)
4.2.2 Global Over-The-Counter (OTC) Pet Medication Sales in Value by Region (2020-2025)
4.2.3 Global Over-The-Counter (OTC) Pet Medication Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Region
4.3.1 Global Over-The-Counter (OTC) Pet Medication Sales in Volume by Region (2026-2031)
4.3.2 Global Over-The-Counter (OTC) Pet Medication Sales in Value by Region (2026-2031)
4.3.3 Global Over-The-Counter (OTC) Pet Medication Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Over-The-Counter (OTC) Pet Medication by Application
5.1 Over-The-Counter (OTC) Pet Medication Market by Application
5.1.1 Online Sales
5.1.2 Offline Sales
5.2 Global Over-The-Counter (OTC) Pet Medication Market Size by Application
5.2.1 Global Over-The-Counter (OTC) Pet Medication Market Size Overview by Application (2020-2031)
5.2.2 Global Over-The-Counter (OTC) Pet Medication Historic Market Size Review by Application (2020-2025)
5.2.3 Global Over-The-Counter (OTC) Pet Medication Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2020-2025)
5.3.2 Europe Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2020-2025)
5.3.4 South America Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Merck Animal Health
6.1.1 Merck Animal Health Comapny Information
6.1.2 Merck Animal Health Business Overview
6.1.3 Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio
6.1.5 Merck Animal Health Recent Developments
6.2 Elanco
6.2.1 Elanco Comapny Information
6.2.2 Elanco Business Overview
6.2.3 Elanco Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio
6.2.5 Elanco Recent Developments
6.3 Zoetis
6.3.1 Zoetis Comapny Information
6.3.2 Zoetis Business Overview
6.3.3 Zoetis Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio
6.3.5 Zoetis Recent Developments
6.4 Virbac
6.4.1 Virbac Comapny Information
6.4.2 Virbac Business Overview
6.4.3 Virbac Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio
6.4.5 Virbac Recent Developments
6.5 Vet's Best
6.5.1 Vet's Best Comapny Information
6.5.2 Vet's Best Business Overview
6.5.3 Vet's Best Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio
6.5.5 Vet's Best Recent Developments
6.6 Vetoquinol
6.6.1 Vetoquinol Comapny Information
6.6.2 Vetoquinol Business Overview
6.6.3 Vetoquinol Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio
6.6.5 Vetoquinol Recent Developments
6.7 Sentry
6.7.1 Sentry Comapny Information
6.7.2 Sentry Business Overview
6.7.3 Sentry Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio
6.7.5 Sentry Recent Developments
6.8 Purdue Pharma L.P.
6.8.1 Purdue Pharma L.P. Comapny Information
6.8.2 Purdue Pharma L.P. Business Overview
6.8.3 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio
6.8.5 Purdue Pharma L.P. Recent Developments
6.9 PetIQ
6.9.1 PetIQ Comapny Information
6.9.2 PetIQ Business Overview
6.9.3 PetIQ Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.9.4 PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio
6.9.5 PetIQ Recent Developments
6.10 Perrigo
6.10.1 Perrigo Comapny Information
6.10.2 Perrigo Business Overview
6.10.3 Perrigo Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio
6.10.5 Perrigo Recent Developments
6.11 Nutramax Laboratories
6.11.1 Nutramax Laboratories Comapny Information
6.11.2 Nutramax Laboratories Business Overview
6.11.3 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio
6.11.5 Nutramax Laboratories Recent Developments
6.12 Mobedco-Vet
6.12.1 Mobedco-Vet Comapny Information
6.12.2 Mobedco-Vet Business Overview
6.12.3 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio
6.12.5 Mobedco-Vet Recent Developments
6.13 Ceva Santé Animale
6.13.1 Ceva Santé Animale Comapny Information
6.13.2 Ceva Santé Animale Business Overview
6.13.3 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio
6.13.5 Ceva Santé Animale Recent Developments
6.14 Boehringer Ingelheim
6.14.1 Boehringer Ingelheim Comapny Information
6.14.2 Boehringer Ingelheim Business Overview
6.14.3 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio
6.14.5 Boehringer Ingelheim Recent Developments
6.15 Antelope Pets
6.15.1 Antelope Pets Comapny Information
6.15.2 Antelope Pets Business Overview
6.15.3 Antelope Pets Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio
6.15.5 Antelope Pets Recent Developments
7 North America by Country
7.1 North America Over-The-Counter (OTC) Pet Medication Sales by Country
7.1.1 North America Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Over-The-Counter (OTC) Pet Medication Sales by Country (2020-2025)
7.1.3 North America Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2026-2031)
7.2 North America Over-The-Counter (OTC) Pet Medication Market Size by Country
7.2.1 North America Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Over-The-Counter (OTC) Pet Medication Market Size by Country (2020-2025)
7.2.3 North America Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Over-The-Counter (OTC) Pet Medication Sales by Country
8.1.1 Europe Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2020-2025)
8.1.3 Europe Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2026-2031)
8.2 Europe Over-The-Counter (OTC) Pet Medication Market Size by Country
8.2.1 Europe Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Over-The-Counter (OTC) Pet Medication Market Size by Country (2020-2025)
8.2.3 Europe Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales by Country
9.1.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2020-2025)
9.1.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country
9.2.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Over-The-Counter (OTC) Pet Medication Sales by Country
10.1.1 South America Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Over-The-Counter (OTC) Pet Medication Sales by Country (2020-2025)
10.1.3 South America Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2026-2031)
10.2 South America Over-The-Counter (OTC) Pet Medication Market Size by Country
10.2.1 South America Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Over-The-Counter (OTC) Pet Medication Market Size by Country (2020-2025)
10.2.3 South America Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country
11.1.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2020-2025)
11.1.3 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country
11.2.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Over-The-Counter (OTC) Pet Medication Value Chain Analysis
12.1.1 Over-The-Counter (OTC) Pet Medication Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Over-The-Counter (OTC) Pet Medication Production Mode & Process
12.2 Over-The-Counter (OTC) Pet Medication Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Over-The-Counter (OTC) Pet Medication Distributors
12.2.3 Over-The-Counter (OTC) Pet Medication Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings